Corcept Therapeutics
CORT
#1843
Rank
NZ$14.78 B
Marketcap
$140.18
Share price
-2.46%
Change (1 day)
229.96%
Change (1 year)

P/S ratio for Corcept Therapeutics (CORT)

P/S ratio as of April 2025 (TTM): 13.1

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 13.0. At the end of 2024 the company had a P/S ratio of 8.14.

P/S ratio history for Corcept Therapeutics from 2007 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20248.1417.34%
20236.9427.57%
20225.44-12.9%
20216.25-27.27%
20208.5989.9%
20194.52-26.07%
20186.12-52.75%
201712.930.61%
20169.91-8.71%
201510.9-5.22%
201411.5-62.98%
201330.9-28.3%
201243.2
2011N/A
2010N/A-100%
2009> 10006549.54%
200887.1-60.46%
2007220

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.22-67.82%๐Ÿ‡บ๐Ÿ‡ธ USA
2.51-80.83%๐Ÿ‡บ๐Ÿ‡ธ USA
4.23-67.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
16.3 24.53%๐Ÿ‡บ๐Ÿ‡ธ USA
2.20-83.19%๐Ÿ‡บ๐Ÿ‡ธ USA
3.41-73.97%๐Ÿ‡บ๐Ÿ‡ธ USA
0.8276-93.68%๐Ÿ‡บ๐Ÿ‡ธ USA
5.34-59.21%๐Ÿ‡บ๐Ÿ‡ธ USA
4.57-65.13%๐Ÿ‡บ๐Ÿ‡ธ USA